Researchers at the National University of Singapore (NUS) have developed a new personalized tool to detect cancer, predict survival and how well patients respond to immunotherapy. The tool is designed as a scorecard, and is used with blood samples collected from patients (also known as liquid biopsies).

Thyroid cancer is most often diagnosed in men and women between the ages of 45 and 54. It is the most commonly diagnosed cancer in women aged 20 to 34 years. Women are about three times more likely to develop thyroid cancer than men. Therefore, screening tests for thyroid cancer are important for early detection and treatment.